LaWanda and Lloyd Cox knew immediately something was wrong. They could see it in the face of the Baltimore County emergency room doctor as she pressed on their 9-year-old daughter's stomach.
This wasn't the flu or a virus "that would have to run its course," as other doctors first thought. This was more serious. After a sonogram revealed lesions on the girl's liver, she was whisked away by ambulance to the University of Maryland Children's Hospital.
The diagnosis was excruciating: Their daughter, Khloe, had a rare cancer that usually affects people older than 50. "This has to be a nightmare," Lloyd Cox recounted thinking Thursday as his daughter, now 11, sat sandwiched between him and his wife on a couch at the Ronald McDonald House in Minneapolis. "I wanted someone to wake me up and tell me it wasn't true."
After coming to grips with the diagnosis and making the rounds to medical specialists, they found hope in Minnesota and a first-of-its kind transplant surgery that may not only give their daughter a longer life but also help other cancer patients.
Khloe's diagnosis was for the same type of cancer — a neuroendocrine tumor — that struck down Apple founder Steve Jobs. It's rare in adults and even more so in children.
The cancer that started in Khloe's pancreas had spread to her liver. Specialists at the University of Iowa Hospitals and Clinics began a treatment course to stabilize the cancer. But it wasn't going to cure it, said Dr. Srinath Chinnakotla, surgical director of liver transplantation with M Health Fairview.
Khloe's dreams of growing up to be a NASA scientist would likely be cut short unless they could replace her pancreas and liver.
Chinnakotla had performed one other dual pancreas-liver transplant, but this would be the first time it would be done to treat this type of cancer. The risks would be high.